Sign In
test

Paul Paolino

Krensavage Asset Management, Llc

Assets Managed
$255.697M
Holdings
20
Last Quarter
2026 - Q1
Filed Date
27d ago
Growth Rate
-9.68%(2Q avg: 5.48%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Krensavage Asset Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of Krensavage Asset Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 255.697M in assets, with a quarterly growth rate of -9.68% and a 2-quarter average growth rate of 5.48%. The portfolio is managed by Paul Paolino, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
UTHR
United Therapeutics Corp
Recent Activity
Decreased -7.66%
19.55%
$49.978M
84,282 shares@ $592.99 avg price
ENTA
Enanta Pharmaceuticals Inc
Recent Activity
Increased 3.61%
14.16%
$36.199M
2.866M shares@ $12.63 avg price
JAZZ
Jazz Pharmaceuticals Plc
Recent Activity
12.41%
$31.726M
167,816 shares@ $189.06 avg price
BMRN
Biomarin Pharmaceutical Inc
Recent Activity
11.6%
$29.645M
524,786 shares@ $56.49 avg price
EXEL
Exelixis Inc
Recent Activity
Decreased -15.77%
6.98%
$17.829M
415,693 shares@ $42.89 avg price
SNY
Sanofi-adr
Recent Activity
6.11%
$15.608M
323,946 shares@ $48.19 avg price
SUPN
Supernus Pharmaceuticals Inc
Recent Activity
Decreased -10.46%
5.68%
$14.508M
280,681 shares@ $51.69 avg price
INDV
Indivior Pharmaceuticals Inc
Recent Activity
New Position
4.05%
$10.349M
339,532 shares@ $30.49 avg price
RARE
Ultragenyx Pharmaceutical In
Recent Activity
Increased 161.23%
3.21%
$8.189M
390,879 shares@ $20.96 avg price
VNDA
Vanda Pharmaceuticals Inc
Recent Activity
3.19%
$8.156M
1.18M shares@ $6.91 avg price

1-10 of 20